Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.Investors Business Daily • 09/26/24
Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEOReuters • 09/26/24
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide MarketsBusiness Wire • 09/25/24
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European UnionBusiness Wire • 09/20/24
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold ForeverThe Motley Fool • 09/18/24
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with AnalystsBusiness Wire • 09/17/24
Buy 3 High Dividend-Paying Stocks With Attractive Short-Term ReturnsZacks Investment Research • 09/16/24